Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
about
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.Successful Treatment of Transplant Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide
P2860
Q33256286-870996CD-BF34-4EAB-AA4A-54037D6EE6A8Q33368614-D8110BBF-8487-4A36-BD45-9D0C30A462EEQ33393068-336F376F-67FB-4CFA-BB71-FA8498C34132Q33394558-488DAEAE-A296-46BA-ACD1-B9E04563D4E1Q33395998-521B60B0-43C0-4CBD-8B69-A427DAC4340DQ33417613-628CBBD1-37BF-41A8-AFB4-772FDBFCB1FEQ33424902-84B5E2C2-E924-46CC-872C-C12DD71841EBQ36585425-2C430D6C-2037-4B3B-ABAC-65CA77BC3DE6Q48346280-9AC6EE7A-8420-4174-9133-FADAA1A89935Q50622232-AD0D6F05-9432-45BA-9CBB-588DE943CEFAQ56529806-73BE0949-A4C2-4B10-B66F-C91E3404DF52
P2860
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@ast
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@en
type
label
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@ast
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@en
prefLabel
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@ast
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@en
P2093
P1433
P1476
Thrombotic microangiopathy aft ...... prednisolone T-cell depletion.
@en
P2093
Arif Raza Alam
Barbara Bambach
David Lawrence
James L Slack
Joanne Becker
Joaquin Silva
Laurieann Ford
Maria R Baer
Meir Wetzler
Myron S Czuczman
P304
P356
10.1097/01.TP.0000141363.81600.0D
P577
2004-11-01T00:00:00Z